BioAtla, Inc.
For the period ended Dec 31, 2024. Filed Mar 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 28, 2025
BCAB$1.74-44.7%Stored close · as of Aug 28, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets
(in thousands, except share amounts)
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $49,046 | $111,471 |
| Prepaid expenses and other current assets | 2,186 | 4,935 |
| Total current assets | 51,232 | 116,406 |
| Property and equipment, net | 678 | 1,603 |
| Operating lease right-of-use-asset, net | 512 | 1,495 |
| Other assets | — | 154 |
| Total assets | $52,422 | $119,658 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable and accrued expenses | $13,704 | $26,720 |
| Operating lease liabilities | 836 | 1,624 |
| Total current liabilities | 14,540 | 28,344 |
| Operating lease liabilities, less current portion | — | 836 |
| Liability to licensor | 19,806 | 19,806 |
| Warrant liability | 3,811 | — |
| Total liabilities | 38,157 | 48,986 |
| Commitments and contingencies (Note 5) | ||
| Stockholders' equity: | ||
| Preferred stock, $0.0001 par value; 200,000,000 shares authorized at December 31, 2024 and December 31, 2023; 0 shares issued and outstanding at December 31, 2024 and December 31, 2023 | — | — |
| Common stock, $0.0001 par value; 350,000,000 shares authorized at December 31, 2024 and December 31, 2023; 58,099,164 and 48,077,599 shares issued and outstanding at December 31, 2024 and December 31, 2023 | 6 | 5 |
| Class B common stock, $0.0001 par value; 15,368,569 shares authorized at December 31, 2024 and December 31, 2023; 0 shares issued and outstanding at December 31, 2024 and December 31, 2023 | — | — |
| Additional paid-in capital | 500,298 | 486,930 |
| Accumulated deficit | (486,039) | (416,263) |
| Total stockholders' equity | 14,265 | 70,672 |
| Total liabilities and stockholders’ equity | $52,422 | $119,658 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.